STRATA Skin Sciences Inc. (NASDAQ: SSKN), a U.S.-based dermatology and plastic surgery firm, has announced the renewal of exclusive distribution agreements with its two partners for the China and Japan markets. Each agreement spans three years and includes minimum unit placements and purchases for STRATA’s XTRAC and VTRAC devices. The XTRAC excimer laser and VTRAC lamp system are designed to deliver targeted therapeutic beams of light for the treatment of psoriasis, vitiligo, and atopic dermatitis.
The company reported that international revenues accounted for nearly one-third of its total revenue in 2023, with distributors in China and Japan contributing 46% of that international total. STRATA posted total revenues of $33.4 million last year.
STRATA’s distributor in China is believed to be Wuhan Medical Laser Systems Inc., based on a partnership announced in 2021. The Wuhan-based company has maintained a relationship with STRATA for over 15 years.- Flcube.com
